NO950606D0 - Adhesion receptor antagonists - Google Patents

Adhesion receptor antagonists

Info

Publication number
NO950606D0
NO950606D0 NO950606A NO950606A NO950606D0 NO 950606 D0 NO950606 D0 NO 950606D0 NO 950606 A NO950606 A NO 950606A NO 950606 A NO950606 A NO 950606A NO 950606 D0 NO950606 D0 NO 950606D0
Authority
NO
Norway
Prior art keywords
receptor antagonists
adhesion receptor
adhesion
antagonists
receptor
Prior art date
Application number
NO950606A
Other languages
Norwegian (no)
Other versions
NO950606L (en
Inventor
Horst Juraszyk
Joachim Gante
Hanns Wurziger
Sabine Bernotat-Danielowski
Guido Melzer
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO950606D0 publication Critical patent/NO950606D0/en
Publication of NO950606L publication Critical patent/NO950606L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO950606A 1994-02-19 1995-02-17 Adhesion receptor antagonists NO950606L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4405378A DE4405378A1 (en) 1994-02-19 1994-02-19 Adhesion receptor antagonists

Publications (2)

Publication Number Publication Date
NO950606D0 true NO950606D0 (en) 1995-02-17
NO950606L NO950606L (en) 1995-08-21

Family

ID=6510687

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950606A NO950606L (en) 1994-02-19 1995-02-17 Adhesion receptor antagonists

Country Status (15)

Country Link
US (1) US5614531A (en)
EP (1) EP0668278A1 (en)
JP (1) JPH07252254A (en)
KR (1) KR950032197A (en)
CN (1) CN1111630A (en)
AU (1) AU1230795A (en)
CA (1) CA2142741A1 (en)
CZ (1) CZ42495A3 (en)
DE (1) DE4405378A1 (en)
HU (1) HUT71806A (en)
NO (1) NO950606L (en)
PL (1) PL307328A1 (en)
RU (1) RU95102323A (en)
SK (1) SK22195A3 (en)
ZA (1) ZA951345B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100637110B1 (en) * 1996-07-25 2006-10-23 바이오겐 아이덱 엠에이 인코포레이티드 Cell adhesion inhibitors
DE19653646A1 (en) * 1996-12-20 1998-06-25 Hoechst Ag Substituted purine derivatives, processes for their preparation, agents containing them and their use
AR011057A1 (en) * 1997-01-08 2000-08-02 Smithkline Beecham Corp USE OF SUBSTITUTED BIS-ACRIDINES AND RELATED COMPOUNDS FOR THE PREPARATION OF MEDICINES AND SUCH COMPOUNDS
US5902797A (en) * 1997-11-10 1999-05-11 Beth Israel Deaconess Medical Center Nutritional supplement for use in the treatment of attention deficit
AU2593600A (en) 1998-12-23 2000-07-12 G.D. Searle & Co. Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia
DE10117183A1 (en) * 2001-04-05 2002-10-10 Gruenenthal Gmbh Use of substituted imidazo [1,2-a] pyridine compounds as medicaments
DE10117184A1 (en) * 2001-04-05 2002-10-17 Gruenenthal Gmbh Substituted imidazole [1,2-a] pyridin-3-yl amide and amine compounds
ES2450541T3 (en) 2004-06-04 2014-03-25 The Scripps Research Institute Compositions for the treatment of neovascular diseases
JP2008512097A (en) * 2004-09-07 2008-04-24 アーケミックス コーポレイション Aptamer medicinal chemistry
US7566701B2 (en) * 2004-09-07 2009-07-28 Archemix Corp. Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
EP1789096A4 (en) 2004-09-07 2009-07-08 Archemix Corp Aptamers to von willebrand factor and their use as thrombotic disease therapeutics
US7919519B2 (en) * 2005-11-23 2011-04-05 Epix Pharmaceuticals Inc. S1P receptor modulating compounds and use thereof
AU2006317689B2 (en) * 2005-11-23 2013-07-25 Epix Delaware, Inc. S1P receptor modulating compounds and use thereof
CA2631259A1 (en) * 2005-11-28 2007-06-07 Mallinckrodt Inc. Improved method of preparation for imidazolepyridines
JP2009530389A (en) * 2006-03-21 2009-08-27 エピックス デラウェア， インコーポレイテッド S1P receptor modulating compounds and uses thereof
US7563797B2 (en) * 2006-08-28 2009-07-21 Forest Laboratories Holding Limited Substituted imidazo(1,2-A)pyrimidines and imidazo(1,2-A) pyridines as cannabinoid receptor ligands
EP1964840A1 (en) 2007-02-28 2008-09-03 sanofi-aventis Imidazo[1,2-a]pyridines and their use as pharmaceuticals
JP5191497B2 (en) * 2007-03-21 2013-05-08 エピックス ファーマシューティカルズ，インコーポレイテッド S1P receptor modulating compounds and uses thereof
WO2008150495A2 (en) * 2007-06-01 2008-12-11 Archemix Corp. Vwf aptamer formulations and methods for use
JP2010540438A (en) * 2007-09-20 2010-12-24 アムジエン・インコーポレーテツド 1- (4-Benzylbenzamido) -benzyl) azetidine-3-carboxylic acid derivatives and related compounds as S1P receptor modulators for treating immune disorders
US7868001B2 (en) * 2007-11-02 2011-01-11 Hutchison Medipharma Enterprises Limited Cytokine inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593818B1 (en) * 1986-02-05 1988-04-29 Synthelabo IMIDAZO (1,2-A) PYRIDINE ACYLAMINOMETHYL-3 DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
ES2032455T3 (en) * 1986-01-22 1993-02-16 Synthelabo PROCEDURE FOR PREPARING DERIVATIVES OF 3-ACILAMINOMETIL-IMIDAZO (-1,2-A) PIRIDINAS.
US4990506A (en) * 1986-02-05 1991-02-05 Synthelabo 3-(acylaminomethyl)imidazo[1,2-a]pyridine derivatives and their application in therapy
US4791117A (en) * 1986-09-22 1988-12-13 Ortho Pharmaceutical Corporation 2- or 3-aryl substituted imidazo[1,2-a]pyridines and their use as calcium channel blockers
FR2606410B1 (en) * 1986-11-07 1989-02-24 Synthelabo IMIDAZOPYRIDINES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS
US5053393A (en) * 1988-07-20 1991-10-01 Monsanto Company Novel platelet-aggregation inhibitor
US5084466A (en) * 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
US5256812A (en) * 1989-01-31 1993-10-26 Hoffmann-La Roche Inc. Carboxamides and sulfonamides
DE4017211A1 (en) * 1990-05-29 1991-12-05 Merck Patent Gmbh OXAZOLIDINONE
US5321034A (en) * 1991-05-07 1994-06-14 Merck & Co., Inc. Fibrinogen receptor antagonists
HUT68769A (en) * 1991-05-07 1995-07-28 Merck & Co Inc FIBRINOGéN RECEPTOR ANTAGONIST COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AS EFFECTIVE SUBSTANCE
DE4129603A1 (en) * 1991-09-06 1993-03-11 Thomae Gmbh Dr K CONDENSED 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF, AND MEDICAMENTS CONTAINING THESE COMPOUNDS
US5272158A (en) * 1991-10-29 1993-12-21 Merck & Co., Inc. Fibrinogen receptor antagonists
AU3648993A (en) * 1992-03-17 1993-10-21 Nippon Shinyaku Co. Ltd. Imidazopyridine derivative and medicine
DE4327027A1 (en) * 1993-02-15 1994-08-18 Bayer Ag Imidazoazine

Also Published As

Publication number Publication date
HU9500479D0 (en) 1995-04-28
KR950032197A (en) 1995-12-20
AU1230795A (en) 1995-08-31
ZA951345B (en) 1995-10-24
EP0668278A1 (en) 1995-08-23
US5614531A (en) 1997-03-25
CN1111630A (en) 1995-11-15
DE4405378A1 (en) 1995-08-24
NO950606L (en) 1995-08-21
HUT71806A (en) 1996-02-28
JPH07252254A (en) 1995-10-03
CZ42495A3 (en) 1995-10-18
PL307328A1 (en) 1995-08-21
SK22195A3 (en) 1995-09-13
CA2142741A1 (en) 1995-08-20
RU95102323A (en) 1997-03-20

Similar Documents

Publication Publication Date Title
NO972016D0 (en) Indolyl-Y receptor antagonists
DE69734833D1 (en) VITRONEKTIN RECEPTOR ANTAGONISTS
DE69812096D1 (en) NEUROPEPTID Y RECEPTOR ANTAGONISTS
BR9508178A (en) Vitronectin receptor antagonists
DK1009732T3 (en) 1-Amino-alkylcyclohexane NMDA receptor antagonists
BR9612381A (en) Vitronectin receptor antagonists
DK0738150T3 (en) Bicyclic fibrinogenic antagonists
ATE258548T1 (en) ADHESION RECEPTOR ANTAGONISTS
FI960953A (en) endothelin receptor antagonists
NO950606D0 (en) Adhesion receptor antagonists
ID16742A (en) ENDOTELIN RECEPTOR ANTAGONISTS
ID23168A (en) VITRONEKTIN ANATAGONICAL RECEPTORS
ID24726A (en) TROMBIN RECEPTOR ANTAGONISTS
ID24162A (en) VITRONECTTIN RECEPTOR ANTAGONISTS
DK0906294T3 (en) Benzoxazinone-dopamine D4 receptor antagonists
BR9507220A (en) Endothelin receptor antagonists
ZA959434B (en) Adhesion receptor antagonists
DE69513832D1 (en) EXCITATIVE AMINO ACID RECEPTOR ANTAGONISTS
DE69616364D1 (en) ENDOTHELINE RECEPTOR ANTAGONISTS
DE69636597D1 (en) ENDOTHELIN RECEPTOR ANTAGONISTS
ZA961159B (en) Adhesion receptor antagonists
BR9603432A (en) Endothelin receptor antagonists
DE59503324D1 (en) Adhesion receptor antagonists
FI972558A (en) New receptor
ID22978A (en) ENDOTELIN RECEPTOR ANTAGONISTS